Neuropsychological Development and Executive Functioning of Children Born to HIV- Infected Mothers ( NEUROPSY-HEU )
- Conditions
- HIV InfectionsExposure During PregnancyNeurophysiologic AbnormalityExecutive Dysfunction
- Interventions
- Diagnostic Test: BRIEF SCORE AT INCLUSION
- Registration Number
- NCT04108728
- Lead Sponsor
- Nantes University Hospital
- Brief Summary
Main objective: to evaluate the executive functioning of the HIV exposed uninfected children (HEU) versus children from the same socio-economic and cultural environment, not infected or affected by HIV.
Secondary objective (s): to evaluate Intellectual Quotient, Child development, Behavior, Language and investigate link between executive functioning disorders, exposure to ARVs, HIV and family environment.
- Detailed Description
The objective of the study is the exploration of executive functions (EF) and screening for neurodevelopment and learning disorders in children born to HIV-infected mothers, exposed to the virus and to antiretrovirals (ARVs).
The evaluation of the executive functioning will be done by the score obtained at the preschool BRIEF for patients and control group issued from questionnaires filled by the mothers of the cases and the mothers of the controls, with matching on age, sex, level of parental education and socio-economic and cultural environment.
Within the group of exposed children, factors associated with executive dysfunction including HIV infection, antiretroviral exposure, maternal socio-demographic data, sociocultural and environmental level will be investigated.
Evolution of the scores between J0, M12 and M24 will be compared within the group of exposed children.
Compared with a control group, the child's intelligence quotient, overall development, behavior and language will be compared at each follow-up time (D0, M12 and M24).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 32
-
experimental:
- HIV-positive children born to mothers living with HIV antiretrovirals during pregnancy and in the neonatal period, aged 3 years +/- 3 months on the date of inclusion.
- Parents mastering the French.
-
control:
- children, aged 3 years +/- 3 months on the date of inclusion, from the same socio-economic and cultural environment, no infected or affected by HIV.
- Parents mastering French.
- great prematurity (28-32 weeks)
- genetic anomaly
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description HIV exposed children during pregnancy BRIEF SCORE AT INCLUSION children born from HIV-infected mother, exposed to antiretroviral drugs during pregnancy and in the neonatal period; aged 3 years-old +/- 3 months on the date of inclusion. Parents mastering french language control children BRIEF SCORE AT INCLUSION children, aged 3 years +/- 3 months on the date of inclusion, from the same socio-economic and cultural environment, not infected or affected by HIV. Parents mastering French language.
- Primary Outcome Measures
Name Time Method evaluate the executive function of children HEU inclusion Behaviour rating inventary of executive function (BRIEF) preschool version score
- Secondary Outcome Measures
Name Time Method behaviour at INCLUSION, 12 months after inclusion, 24 months after inclusion Strengths and Difficulties Questionnaire score
functional development at INCLUSION, 12 months after inclusion, 24 months after inclusion age and stage questionnaires score
Intellectual quotient at INCLUSION, 12 months after inclusion, 24 months after inclusion Wechsler tests score
language 12 months after inclusion, language dysfunction scale score
Trial Locations
- Locations (3)
Chu Angers
🇫🇷Angers, France
Chd Vendee
🇫🇷La Roche-sur-Yon, France
Chu de Nantes
🇫🇷Nantes, France